Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Recent studies suggest the beneficial effects of metformin on glucose metabolism may be microbially mediated. We examined the association of type 2 diabetes, metformin, and gut microbiota in community-dwelling Colombian adults. On the basis of previous research, we hypothesized that metformin is associated with higher levels of short-chain fatty acid (SCFA)–producing and mucin-degrading microbiota. RESEARCH DESIGN AND METHODS: Participants were selected from a larger cohort of 459 participants. The present analyses focus on the 28 participants diagnosed with diabetes—14 taking metformin— and the 84 participants without diabetes who were matched (3-to-1) to participants with diabetes by sex, age, and BMI. We measured demographic information, anthropometry, and blood biochemical parameters and collected fecal samples from which we performed 16S rRNA gene sequencing to analyze the composition and structure of the gut microbiota. RESULTS: We found an association between diabetes and gut microbiota that was modified by metformin use. Compared with participants without diabetes, participants with diabetes taking metformin had higher relative abundance of Akkermansia muciniphila, a microbiota known for mucin degradation, and several gut microbiota known for production of SCFAs, including Butyrivibrio, Bifidobacterium bifidum, Megasphaera, and an operational taxonomic unit of Prevotella. In contrast, compared with participants without diabetes, participants with diabetes not taking metformin had higher relative abundance of Clostridiaceae 02d06 and a distinct operational taxonomic unit of Prevotella and a lower abundance of Enterococcus casseliflavus. CONCLUSIONS: Our results support the hypothesis that metformin shifts gut microbiota composition through the enrichment of mucin-degrading A. muciniphila as well as several SCFA-producing microbiota. Future studies are needed to determine if these shifts mediate metformin’s glycemic and anti-inflammatory properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Biguanides/metformin, the first-line therapeutics for T2D, modifies microbiota leading to an increase in A. muciniphila, as well as several SCFA-producing microbiota, favoring an improvement on mucin-producing goblet cells, pro-inflammatory IL-6, and glucose tolerance [304].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [304]
In the citing paper
“In human diabetic individuals, metformin was shown to shift gut microbiota composition to predominantly short-chain fatty-acid producing microbes”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as de la Cuesta-Zuluaga et al. 2017
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192 · cited 2×
“pairwise tests among groups of participants using the unpaired Wilcoxon rank sum test, and finally uses LDA to estimate the effect size of each differentially abundant OTU (24).”
MethodKozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., & Schloss, P. D. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01043-13 · Cited by 7,112
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762 · cited 1×
“Given the considerable variation in the microbiota associated with type 2 diabetes and that the gut microbiota of Colombians is different to that of other populations (18), we hypothesized that the microbial taxa involved in the type 2 diabetes dysbiosis of Colombians are different to those observed in Chinese and Eur…”
BackgroundLinking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513 · cited 1×
“Prevotella has been associated with carbohydrate-baseddiets anddegradation of complex polysaccharides (26), whereas E.”
BackgroundCross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · cited 3×
“abundance of Akkermansia muciniphila (11–13), a mucin-degrading bacteria that has been shown to reverse metabolic disorders (1,12).”
BackgroundInfluentialGut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · cited 1×
“Given the considerable variation in the microbiota associated with type 2 diabetes and that the gut microbiota of Colombians is different to that of other populations (18), we hypothesized that the microbial taxa involved in the type 2 diabetes dysbiosis of Colombians are different to those observed in Chinese and Eur…”
BackgroundGut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851 · cited 1×
“through effects on bile acid secretion (31).”
Cited by
Items 501–600 of 731
Effects of diet-modulated gut microbiota and microbial metabolites in atherosclerosis
Feng, S., Jiang, Y., Jiang, J., Bian, H., & Zhu, R. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119328 · Cited by 10
Shen, C., Elmassry, M. M., Grue, K. A., Joiner, H. E., Jacobo, A. U., Hamood, A. N., & Chung, E. (2022) · Metabolites · doi:10.3390/metabo12100913 · Cited by 9
Lawler, T., Walts, Z. L., Giurini, L., Steinwandel, M. D., Lipworth, L. P., Murff, H. J., Zheng, W., & Andersen, S. W. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102566 · Cited by 9
Jiang, R., Cong, Z., Zheng, L., Zhang, L., Guan, Q., Wang, S., Fang, J., Chen, J., & Liu, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1401070 · Cited by 10
Cheng, M., Jia, X., Ren, L., Chen, S., Wang, W., Wang, J., & Cong, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137250 · Cited by 9
Tseng, C. (2021) · Biomolecules · doi:10.3390/biom11101405 · Cited by 10
“Metformin may alter the gut microbiota leading to an increased production of butyrate, which may in turn reduce insulin resistance and obesity [9,17,18], the important risk factors of meningioma.”
BackgroundDzięgielewska-Gęsiak, S., Fatyga, E., Piłot, M., Wierzgoń, A., & Muc‐Wierzgoń, M. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s377856 · Cited by 10
Zaongo, S. D., & Chen, Y. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002493 · Cited by 10
Boyd, A. C., Dani, M. E., Ajrouche, R., Démontant, V., Cheval, J., Lacombe, K., Cosson, G., Rodriguez, C., Pawlotsky, J., Woerther, P., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.03.016 · Cited by 9
Ray, A. K., Shukla, A., Yadav, A., Kaur, U. S., Singh, A. K., Mago, P., Bhavesh, N. S., Chaturvedi, R., Tandon, R., Shalimar, S., et al. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10847-w · Cited by 11
Makizaki, Y., Maeda, A., Yamamoto, M., Tamura, S., Tanaka, Y., Nakajima, S., & Ohno, H. (2020) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2019-022 · Cited by 9
“In recent years, high levels of Akkermansia species have been reported in the intestine of patients taking metformin [17], and Akkermansia itself has the same antihyperglycemic effect as metformin [5].”
Mucin-munching bacteria modulate glucose metabolism
Geach, T. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.201 · Cited by 9
Sabarathinam, S., Venkatachalapathy, R., & Jayaraman, A. (2024) · Human Gene · doi:10.1016/j.humgen.2024.201364 · Cited by 11
Su, W., Yang, Y., Cheng, J., Dong, N., Li, Y., Fan, Q., Lin, H., Wu, S., & Wu, C. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf238 · Cited by 8
The effects of phenolic acid supplementation on intestinal barrier function: a review
Xia, L., Lin, X., Zhou, Y., Li, Y., Liao, Y., Lin, Y., Lin, L., Wu, P., & Xie, J. (2025) · Food & Function · doi:10.1039/d5fo03351a · Cited by 10
Wang, Y., Wu, S., Wang, L., Wang, Y., Liu, D., Fu, Y., & Xie, Y. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.865320 · Cited by 11
Possible role of metformin as an antidepressant in diabetes
Pedreáñez, A. B., Carrero, Y. N., Vargas, R., Hernández-Fonseca, J. P., & Mosquera-Sulbarán, J. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.228 · Cited by 8
The role of fecal microbiota transplantation in type 2 diabetes mellitus treatment
Wang, H., Li, S., Zhang, L., & Zhang, N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1469165 · Cited by 9
Zhou, Y., Feng, Y., Zhao, Y., Wu, Y., Li, M., Xi, Y., Wu, X., & Chen, X. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70442 · Cited by 8
“Changes in Butyrivibrio and Prevotellaceae genera, known for their role in short-chain fatty acid (SCFA) production [31, 32], may enhance anti-inflammatory effects both locally and systemically.”
Bramante, C. T., Johnson, S., Garcia, V. L., Evans, M. D., Harper, J. R., Wilkins, K. J., Huling, J. D., Mehta, H. B., Alexander, C., Tronieri, J. S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271574 · Cited by 10
Dietary administration with hydrolyzed silk sericin improves the intestinal health of diabetic rats
Zhou, W., Weng, Y., Liu, Q., Wang, C., Zhang, Y., Zhang, X., & Ye, A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1074892 · Cited by 8
Yew, M. J., Heywood, S. E., Ng, J., West, O. M., Pál, M., Kueh, A. J., Lancaster, G. I., Myers, S., Yang, C., Liu, Y., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15484 · Cited by 8
Metformin and Its Benefits in Improving Gut Microbiota Disturbances in Diabetes Patients
Suceveanu, A., Micu, S. I., Voinea, C., Manea, M. E., Catrinoiu, D., Mazilu, L., Stoian, A. P., Parepa, I. R., Stoica, R. A., & Suceveanu, A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88749 · Cited by 8
Advantages of the use of metformin in patients with impaired uric acid metabolism
Елисеев, М. С., Паневин, Т. С., Zhelyabina, O. V., & Nasonov, E. L. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.05.200795 · Cited by 8
Moving on from Metchnikoff: thinking about microbiome therapeutics in cancer
Vareki, S. M., Chanyi, R. M., Abdur-Rashid, K., Brennan, L., & Burton, J. P. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.867 · Cited by 8
Drug Response Diversity: A Hidden Bacterium?
Hannachi, N., & Camoin‐Jau, L. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050345 · Cited by 9
Zhang, G., Zhong, X., Chen, J., Yang, C., Liu, Y., Li, R., Xu, B., & Yuan, H. (2024) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2024.107887 · Cited by 7
Gul, F., Herrema, H., Ameer, A., Davids, M., Nasir, A., Gerasimidis, K., Ijaz, U. Z., & Javed, S. (2025) · Frontiers in Systems Biology · doi:10.3389/fsysb.2025.1622753 · Cited by 7
FakhriRavari, A., & Nguyen, M. H. (2025) · Gastrointestinal Disorders · doi:10.3390/gidisord7040072 · Cited by 9
Gut microbiome and prediabetes - a review
Rathi, K. K., Kumari, N., Javaid, M. D., Saleem, U., Mortensen, E. M., Zhou, Y., & Maheshwari, N. (2023) · Frontiers in Bacteriology · doi:10.3389/fbrio.2023.1242297 · Cited by 9
Microbiome therapeutic PMC72 through reverse translational research in gout
Hossain, M. S., Seo, H., Lee, K., Ul-Haq, A., Kim, S., Jo, S., Rahim, M. A., Tajdozian, H., Ghorbanian, F., Yoon, Y., et al. (2025) · The Journal of Microbiology · doi:10.71150/jm.2501002 · Cited by 7
“For instance, Akkermansia muciniphila alleviates metabolic disorders, enhances the effectiveness of metformin in cancer treat-ment, and protects against atherosclerosis by reducing gut permeability and inflammation (Cuesta-Zuluaga et al., 2017; Li et al., 2016; Verdura et al., 2019).”
Liang, S., Sun, Y., Miao, Z., Li, B.-Y., Xing, Z., Xie, Y., Cai, E., Li, S., Liu, P., Yang, M., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.02.012 · Cited by 10
WATANABE, S., Akiko, O. H. N. O., Yomoda, S., & INAMASU, S. (2022) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2021-070 · Cited by 7
“muciniphila increases in response to a ketogenic diet [7], starvation during fasting [8], and administration of metformin (MF), a therapeutic drug for diabetes [9].”
BackgroundEffect of fecal preservation method on captive southern white rhinoceros gut microbiome
Burnham, C. M., McKenney, E. A., Heugten, K. A., Minter, L. J., & Trivedi, S. (2023) · Wildlife Society Bulletin · doi:10.1002/wsb.1436 · Cited by 7
Xie, Y., Xu, D., Yan, S., Hu, X., Chen, S., Guo, K., Wang, J., Chen, Q., & Guan, W. (2023) · The FASEB Journal · doi:10.1096/fj.202300179rr · Cited by 7
Lee, G. C., Moreira, A. G., Hinojosa, C. A., Benavides, R., Winter, C., Anderson, A. C., Chen, C.-J., Borsa, N., Hastings, G., Black, C. A., et al. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.736835 · Cited by 8
Distinct Gut Microbiome Signatures in Hemodialysis and Kidney Transplant Populations
Voroneanu, L. E., Covic, A. S., Iliescu, Ș., Băluţă, C. V., Agavriloaei, B. D., Stefan, A. E., Amărandi, R.-M., Văcărean-Trandafir, I.-C., Ivanov, I.-C., & Covic, A. C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14228032 · Cited by 7
“However, it has been recently pointed out that specific antidiabetic medication can increase levels of Akkermansia , potentially suggesting a medication-induced restoration of gut dysbiosis associated with type 2 diabetes [33].”
Role of Akkermansia muciniphila in improving gut health for the prevention of type 2 diabetes
Subburaj, S., Thirumalaisamy, S., Jacob, J., & Vijayababu, P. (2026) · Advances in Biomarker Sciences and Technology · doi:10.1016/j.abst.2026.01.002 · Cited by 8
Gut microbiota and metabolic disease risk in youth
Xie, Q. Y., Hamilton, J. K., & Danska, J. S. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102571 · Cited by 6
Yang, P., Liu, J., Wang, L., Qiu, H., & Zhang, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1308016 · Cited by 6
Zhou, W., Zhan, L., Xu, H., & Zhang, L. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220692 · Cited by 6
“Participants with diabetes have a higher relative abundance of 02d06 [64].”
Zhang, Y., Wei, X., Sun, Q., Qian, W., Liu, X., Li, J., Long, Y., & Wan, X. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c04291 · Cited by 7
Robeson, M. S., Manna, K., Randolph, C., Byrum, S. D., & Hakkak, R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.834776 · Cited by 6
The Role of the Gut Microbiome Dysbiosis in Metabolic Dysfunction: A Mini Review
Shafik, A. N., Fahim, V. F., Iskander, F. A., Elsayegh, H. A., Serag, H., & Sallam, H. S. (2025) · Healthcare · doi:10.3390/healthcare13233029 · Cited by 7
Martínez-Nortes, M. E., Carrascosa, C., Ávila‐Gálvez, M. Á., & Espín, J. C. (2026) · Maturitas · doi:10.1016/j.maturitas.2026.108830 · Cited by 6
Mechanistic Links Between the Gut Microbiome and Longevity Therapeutics
Garzon-Escamilla, N., Medina-Cardena, M., Roy, P., Trent, J., Jamous, J., Somesan, Y., & Denslow, S. (2026) · Biomedicines · doi:10.3390/biomedicines14020316 · Cited by 7
Metformin beyond Glycemic Control: New Mechanistic Insights and Expanding Therapeutic Horizons
Han, E., Nam, J. H., Lee, I., Ku, C. R., & Lee, Y. (2026) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2026.0248 · Cited by 7
Feldman, F., Koudoufio, M., Sané, A. T., Marcil, V., Sauvé, M. F., Butcher, J., Patey, N., Martel, C., Spahis, S., Duan, H., et al. (2025) · Antioxidants · doi:10.3390/antiox14030268 · Cited by 5
“Moreover, the observed decreases are often reversed upon therapeutic interventions [101,102].”
Mechanisms of Beneficial Effects of Probiotics in Diabetes Mellitus
Sharma, V., Singh, T. G., Dhiman, S., & Garg, N. (2022) · Springer eBooks · doi:10.1007/978-981-16-8444-9_6 · Cited by 6
Kumari, M., & Kokkiligadda, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822909-5.00004-6 · Cited by 6
Maniar, K., Singh, V., Kumar, D., Moideen, A., Bhattacharyya, R., & Banerjee, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00042-7 · Cited by 5
Unveiling the gut-kidney dialogue in diabetic kidney disease
Gembillo, G., Soraci, L., & Visconti, L. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i11.112440 · Cited by 5
Dumitru, C. N., Dumitru, A. O., Goroftei, L., Niculet, E., Ignat, M. D., Baroiu, L., Nechita, A., & Balan, G. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18060651 · Cited by 4
Gao, J., Wei, W., Ji, C., Pan, X., Chang, J., Zhang, Q., Zhao, X., Jiang, X., Zhang, R., Che, L., et al. (2024) · Animals · doi:10.3390/ani14233356 · Cited by 4
Xu, W., Guan, Y., Tian, L., Fu, Y. V., Zhang, Y., Liu, Y., Hu, Y., Zhao, B., & Wu, C. (2025) · Current Microbiology · doi:10.1007/s00284-025-04391-y · Cited by 4
“Notably, treatment with metformin has been shown to increase the abundance of Akkermansia muciniphila in the mucous layer [8].”
Obstructive sleep apnea and the gut microbiota – mechanisms and opportunities
Alcock, J. (2025) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000001211 · Cited by 5
Molavi, M., Amin, B., & Sahebkar, M. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-04222-9 · Cited by 4
Motte, L. R. D. L., Carreras, F., & Drago, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1858420 · Cited by 4
“These changes have been linked to improvements in insulin sensitivity and metabolic parameters, potentially through modulation of the gut – pancreas hormonal axis (139).”
Grechkina, V. V., Sheida, E. V., & Kvan, O. V. (2024) · Agrarian science · doi:10.32634/0869-8155-2024-381-4-54-58 · Cited by 4
Napoli, T. F., Cortez, R. V., Sparvoli, L. G., Taddei, C. R., & Salles, J. E. N. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003964 · Cited by 6
“This is obviously an observation for further research and way beyond the scope and reach of our work but certainly not neglectable and an important path to be explored.”
BackgroundPrecision Medicine in Diabetes
Dawed, A. Y., Haider, E., & Pearson, E. R. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2022_590 · Cited by 5
Clinical efficacy of metformin in familial adenomatous polyposis and the effect of intestinal flora
Zhou, L., Zheng, L., Xu, B., Zhou, Y., Li, D., & Wang, W. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03064-6 · Cited by 4
Ito, J., Hagi, K., Kochi, K., Ueki, K., Watada, H., & Kaku, K. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14396 · Cited by 5
Akkermansia muciniphila – multifunctional bacteria
Wosińska, A., PAZIK, D., Łopuszyńska, I., KOSECKA, K., Rudziński, P., Cieślik, A., Jargieło, A., KOSIERADZKA, K., ADAMOWICZ, D., & Stańczyk, J. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.21.01.009 · Cited by 4
Fayfman, M., Gewirtz, A. T., Delaroque, C., Blanco, G., Gibanica, S., Srinivasan, S., & Chassaing, B. (2023) · Metabolism Open · doi:10.1016/j.metop.2023.100256 · Cited by 4
“For example, metformin has been shown to increase the production of mucin-degrading Akkermansia muciniphila and other microbial changes that lead to increased short-chain fatty acid production [5,29,30].”
BackgroundAn, S., Zhen, Z., Wang, S., Sang, M., & Zhang, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03670-8 · Cited by 3
“In summary, these results provide evidence that fecal microbiota transplantation can affect the abundance of intestinal content, and the fecal microbiota after load swimming is different from Shank3 -/- , which may be the reason for behavioral changes.”
A Possible Role of Akkermansia muciniphila in the Treatment of Olanzapine-Induced Weight Gain
Bertossi, F. (2024) · Cureus · doi:10.7759/cureus.55733 · Cited by 5
“…example, metformin exerts a regulating action on gut microbiota, improving Akkermansia muciniphila and SCFAs-producing bacteria, such as Butyrivibrio, Bifidobacterium bifidum , and Megasphaera, while diet and exercise are among the most effective intervention for gut microbiota regulation [57-59].”
BackgroundThe use of exogenous feed enzymes in the nutrition of ruminants
Grechkina, V. V., Sheida, E. V., Kvan, O. V., & Shevchenko, A. D. (2025) · Agrarian science · doi:10.32634/0869-8155-2025-393-04-69-74 · Cited by 3
da Silva, T. C. A., de Oliveira, J. A., de Moraes, L. Â. G., Rosse, I. C., Goés‐Neto, A., Azevedo, V., & Guerra‐Sá, R. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324712 · Cited by 5
“Other medications absorbed by the microbiota may favor the increase of some species by modifying their diversity, for example, in the case of metformin [68–70], a drug used by some participants in our cohort.”
Xu, Y., Ni, Y., Zhou, M., & Gou, X. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178366 · Cited by 5
Campanale, A., Mir, H.-D., Dumais, E., Inserra, A., Flamand, N., Chakravarty, M. M., Gantois, I., Siddiqui, N., Sonenberg, N., Gobbi, G., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111575 · Cited by 3
Yang, W., Yin, L., Xie, Q., Tan, M., Liu, Y., Xu, J., & Wu, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1699600 · Cited by 3
Gut microbiome disparities reflect type 2 diabetes progression and medication status
Kumar, M., Singh, S., Ojha, R., Kriti, M., Park, G., Verma, V., Pal, N., Sharma, P., Shubham, S., Pandey, M. K., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115156 · Cited by 3
“16 We observed that anti-diabetic medications might selectively promote certain bacterial genera such as Akkermansia , 7,8,17–19 yet may reduce over-all microbiome diversity.”
Conclusion and future perspective
Chauhan, N. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00001-x · Cited by 9
Han, S., Chen, Y., Lu, Y., Jia, M., Xu, Y., & Wang, Y. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01746-7 · Cited by 5
Rola mikrobioty jelit i jej metabolitów w przebiegu otyłości i cukrzycy
Raczkowska, A., Arak, K., & Jaworska, K. (2024) · Postępy Biochemii · doi:10.18388/pb.2021_569 · Cited by 3
“Odkrycia te dostarczają dowodów na to, że drobnoustroje jelitowe mogą przyczyniać się do przeciwcukrzycowego działania metfor - miny poprzez szlaki obejmujące degradację mucyny i wy - twarzanie SCFA [76,83].”
BackgroundRomeo, M., Nardo, F. D., Napolitano, C., Basile, C., Palma, C., Vaia, P., Dallio, M., & Federico, A. (2025) · Diabetology · doi:10.3390/diabetology6080079 · Cited by 3
“Metformin has been shown to enhance intestinal barrier integrity [140], stimulate the production of short-chain fatty acids (SCFAs), modulate BA metabolism, and globally improve glucose homeostasis [141,142].”
Managing Glucose Homeostasis Through the Gut Microbiome
Weninger, S. N., Manley, A., & Duca, F. A. (2025) · Annual Review of Physiology · doi:10.1146/annurev-physiol-051524-094728 · Cited by 4
Kp, Z., & Furmanova, O. V. (2018) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.14.2.2018.130564 · Cited by 3
“Имеются также публикации о том, что в механизме гипогликемического действия метформина может иметь значение и микробиота (совокупность микробов в кишечнике) [28].”
A New Understanding of Metformin
Hardie, D. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00099-2 · Cited by 4
Unger, A. L., Jetton, T. L., & Kraft, J. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521004001 · Cited by 3
“Akkermansia muciniphila, a recently discovered genus and species(80), is a mucin-degrading bacterium largely observed as beneficial to systemic metabolism in rodent(81,82) and human studies(73,83,84).”
BackgroundDonnées récentes sur le mécanisme d’action de la metformine dans le diabète de type 2
Foretz, M., Guigas, B., & Viollet, B. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.09.005 · Cited by 3
Metformin, Microbiota and Health
Paz, G. S., & Fernandes, J. (2022) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2022.00032 · Cited by 3
Tsai, S.-T., Lai, Z.-L., Lu, M., Walther-Antonio, M. R. S., Hsu, Y.-Y., Chao, D., Chen, C.-Y., Vettleson-Trutza, S. A., Kuo, J. S., Yang, C.-C., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-26312-6 · Cited by 2
“In a Colombian cohort of 28 diabetic and 84 healthy control participants, diabetic participants taking metformin exhibited higher relative abundances of Akkermansia muciniphila compared to those without diabetes 53 .”
Liang, J., Li, S., Dai, Y., Pi, Z., Liu, J., Li, P., Sun, W., Jiang, T., Xu, T., & Yu, P. (2026) · The FASEB Journal · doi:10.1096/fj.202501534rr · Cited by 3
Hamsho, M., Shkorfu, W., Bensaoua, M., Martins, C. E. C., Hacıbayram, H., Fadel, A., & Ranneh, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1802369 · Cited by 5
“Metformin treatment modulates the gut microbiota by signi fi cantly increasing the abundance of short-chain fatty acid (SCFA)-producing bacteria, including Akkermansia , Lactobacillus , Bi fi dobacterium , Prevotella , Megasphaera , Shewanella , Blautia , and Butyrivibrio (11, 12).”
Legume intake on gut microbiome and glycemia in type 2 diabetes management: narrative review
Hossain, M. A., Agyei, D., Reynolds, A. N., & Kebede, B. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1785186 · Cited by 2
Girigoswami, K., & Girigoswami, A. (2026) · Current Medical Science · doi:10.1007/s11596-026-00198-5 · Cited by 2
Metformin in prediabetes: key mechanisms for the prevention of diabetes and cardiometabolic risks
Babenko, A. Y. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-10-96-103 · Cited by 2
Bariatric Surgery - Past and Present
Kanat, B. H., Kutluer, N., & Doğan, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100966 · Cited by 3
Gut Microbiota and Bariatric Surgery
Bastón-Paz, N., Alonso, M. P., Avendaño, J., Garriga, M. J., & del Campo, R. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.107175 · Cited by 2
Li, K., Liu, P., Ye, J., Liu, M., & Zhu, L. (2024) · Aging · doi:10.18632/aging.205775 · Cited by 4
Metformin in COVID-19: a magical role beyond the hyperglycemia
Chaubey, G. K., Dilawari, R., Modanwal, R., Talukdar, S., Dhiman, A., & Raje, M. (2024) · Exploration of Drug Science · doi:10.37349/eds.2024.00055 · Cited by 4
Zhang, Y., Li, Q., Tan, H., & Nie, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21630-5.00015-0 · Cited by 2
Microbiome-Based Therapeutics: Emerging Trends in Health Biotechnology
Ullah, I., & Yasmin, M. (2024) · Premier journal of science. · doi:10.70389/pjs.100022 · Cited by 3
Ye, Z., Yu, Y., Cao, Z., Ye, Z., Gu, X., Shen, X., Cai, B., Lin, B. C., Ji, C., Qiao, N., et al. (2025) · Pituitary · doi:10.1007/s11102-025-01544-x · Cited by 3
“This enterotype may prove a promoting effect in reinforcing the integrity of the colonic epithelial barrier, reducing oxidative stress, regulating lipid flux, decreasing inflammation in the liver, and improving systemic metabolic disorder [56–60 ].”
Роль імунної системи у механізмі терапевтичної дії метформіну у хворих на цукровий діабет 2-го типу
Kp, Z., Orlenko, V. L., Попова, В. В., Melnichenko, S. V., Saienko, Y. A., Tronko, К. M., Kulikovskaya, A. V., & Ivaskiva, К. Y. (2017) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.13.5.2017.110024 · Cited by 2
“At the same time, there were reports of a favorable therapeutic effect of the association of metformin and GLP-1 preparations [26], and that of a certain role of microbiota (a set of microbes in the intestine) [9].”
BackgroundBa, S., Yudin, S. M., Zagaynova, A. V., & Shevyreva, M. P. (2019) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-2019-4-105-115 · Cited by 3
Metformin as a drug modifyinggut microbiota
Tkach, S. M. (2020) · Clinical endocrinology and endocrine surgery · doi:10.30978/cees-2020-1-72 · Cited by 2
Gut Microbiota in Obesity and Bariatric Surgery: Where Do We Stand?
Georgiou, K. E. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-59642-2_6 · Cited by 4
Metadata
- Authors
- de la Cuesta-Zuluaga, J., Mueller, N. T., Corrales-Agudelo, V., Velásquez-Mejía, E. P., Carmona, J. A., Abad, J. M., & Escobar, J. S.
- Affiliations
- Vidarium—Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Medellin, Colombia
- Johns Hopkins University (US)
- Vidarium - Centro de Investigación en Nutrición Salud y Bienestar (CO)
- Dinámica I.P.S.—Especialista en Ayudas Diagnósticas, Medellin, Colombia
- EPS y Medicina Prepagada Suramericana S.A., Medellin, Colombia
- Corresponding author
- Escobar, Juan S.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-11-14
- Volume
- 40
- Issue
- 1
- Pages
- 54-62
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2553515186
- Cited by
- 704
- References
- 40
- Citations by year
- 2026: 55 · 2025: 69 · 2024: 86 · 2023: 80 · 2022: 106 · 2021: 78 · 2020: 87 · 2019: 62 · 2018: 45 · 2017: 33 · 2016: 1
- FWCI
- 24.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- metformin, Akkermansia muciniphila, gut microbiota, short-chain fatty acids, type 2 diabetes, mucin degradation, Butyrivibrio, Bifidobacterium bifidum, Megasphaera, Prevotella, Clostridiaceae, Enterococcus casseliflavus, fecal microbiota composition, glycemic control
- MeSH terms
- Gastrointestinal Microbiome, Adolescent, Adult, Colombia, Diabetes Mellitus, Type 2, Fatty Acids, Volatile, Feces, Female, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Mucins, RNA, Ribosomal, 16S, Case-Control Studies, Verrucomicrobia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.